
Anthracene-1,4,9,10-tetraol | CAS:476-60-8
Anthracene-1,4,9,10-tetraol
- 名称:醌茜隐色体; 1,4-二羟基蒽醌隐色体 | Anthracene-1,4,9,10-tetraol
- CAS号:476-60-8
- 别名:1,4,9,10-Tetrahydroxy-anthracene; Leucoquinizarin
- 分子式:C14H10O4
- 分子量:242.22
- EINESC号:207-507-8
产品描述
物理化学性质
没有数据 | 没有数据 |
---|
安全数据
没有数据 | 没有数据 |
---|
SDS
来源 | SDS样本 |
---|---|
没有数据 | 没有数据 |
产品合成路线
名称 | CAS号 |
---|
更多
文章
同行评议文献
A liquid chromatographic method for the determination of tolnaftate in pharmaceutical formulations.A K Dash Journal of pharmaceutical and biomedical analysis, 11(9), 847-853 (1993-09-01)
Studies on the mode of action of tolnaftate in Microsporum gypseum.M P Gupta et al.Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology, 29(1), 45-52 (1991-01-01)
Liquid chromatographic determination of tolnaftate in commercial products.R D Thompson et al.Journal - Association of Official Analytical Chemists, 74(4), 603-607 (1991-07-01)
Determination of the physical state of drug in microcapsule and microsphere formulations.A K Dash Journal of microencapsulation, 14(1), 101-112 (1997-01-01)
Biochemical characterization of terbinafine-resistant Trichophyton rubrum isolates.Bertrand Favre et al.Medical mycology, 42(6), 525-529 (2005-02-03)
Study on the supramolecular multirecognition mechanism of beta-naphthol/beta-cyclodextrin/anionic surfactant in a tolnaftate hydrolysis system.Tang Bo et al.The journal of physical chemistry. B, 110(17), 8877-8884 (2006-04-28)
DrugBank 3.0: a comprehensive resource for 'omics' research on drugs.Craig Knox et al.Nucleic acids research, 39(Database issue), D1035-D1041 (2010-11-10)
[New antifungal agents in the treatment of superficial dermatomycoses].H Degreef Annales de dermatologie et de venereologie, 120(1), 21-31 (1993-01-01)
Identification of Hedgehog signaling inhibitors with relevant human exposure by small molecule screening.Robert J Lipinski et al.Toxicology in vitro : an international journal published in association with BIBRA, 24(5), 1404-1409 (2010-05-04)
Nonplanar property study of antifungal agent tolnaftate-spectroscopic approach.D Arul Dhas et al.Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 79(5), 993-1003 (2011-05-14)
[Therapeutic efficacy of a topical tolnaftate preparation in guinea pig model of tinea pedis].H Yamaguchi et al.The Japanese journal of antibiotics, 54(6), 323-330 (2001-08-28)
Two mechanisms of butenafine action in Candida albicans.W Iwatani et al.Antimicrobial agents and chemotherapy, 37(4), 785-788 (1993-04-01)
Assay of tolnaftate and related impurities by isocratic supercritical fluid chromatography.S T Patil et al.Fresenius' journal of analytical chemistry, 367(1), 91-93 (2001-03-03)
Tolnaftate spray treatment during pregnancy.Andrew E Czeizel et al.Reproductive toxicology (Elmsford, N.Y.), 18(3), 443-444 (2004-04-15)
Enhancing effect of N-acetyl-l-cysteine or 2-mercaptoethanol on the in vitro permeation of 5-fluorouracil or tolnaftate through the human nail plate.Y Kobayashi et al.Chemical & pharmaceutical bulletin, 46(11), 1797-1802 (1998-12-10)
NB-002, a novel nanoemulsion with broad antifungal activity against dermatophytes, other filamentous fungi, and Candida albicans.J Pannu et al.Antimicrobial agents and chemotherapy, 53(8), 3273-3279 (2009-05-13)
Characterization of iprodione resistance in Botrytis cinerea from strawberry and blackberry.Anja Grabke et al.Phytopathology, 104(4), 396-402 (2013-10-26)
Antifungal agents of use in animal health--chemical, biochemical and pharmacological aspects.H Vanden Bossche et al.Journal of veterinary pharmacology and therapeutics, 26(1), 5-29 (2003-02-27)
Tea tree oil in the treatment of tinea pedis.M M Tong et al.The Australasian journal of dermatology, 33(3), 145-149 (1992-01-01)
A randomised controlled trial of active chronic otitis media comparing courses of eardrops versus one-off topical treatments suitable for primary, secondary and tertiary healthcare settings.J W Loock Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery, 37(4), 261-270 (2012-07-19)
Current therapy of dermatophytosis.H J Degreef et al.Journal of the American Academy of Dermatology, 31(3 Pt 2), S25-S30 (1994-09-01)
Ototoxicity of common topical antimycotic preparations.L W Tom The Laryngoscope, 110(4), 509-516 (2000-04-14)
Allergic contact dermatitis from tolnaftate.R González Pérez et al.Contact dermatitis, 32(3), 173-173 (1995-03-01)
Antifungal activity of the new agent latoconazole in two tinea models.T Ohmi et al.Arzneimittel-Forschung, 41(8), 847-851 (1991-08-01)
Assay of tolnaftate in human skin samples after in vitro penetration studies using high performance liquid chromatography.Toma Kezutyte et al.Acta poloniae pharmaceutica, 67(4), 327-334 (2010-07-20)
X-ray powder diffractometric method for quantitation of crystalline drug in microparticulate systems. I. Microspheres.A K Dash et al.Journal of pharmaceutical sciences, 91(4), 983-990 (2002-04-12)
Current concepts in systemic and topical therapy for superficial mycoses.Larry E Millikan Clinics in dermatology, 28(2), 212-216 (2010-03-30)
Study of tolnaftate release from fatty acids containing ointment and penetration into human skin ex vivo.Toma Kezutyte et al.Acta poloniae pharmaceutica, 68(6), 965-973 (2011-12-01)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!